Search

Your search keyword '"AbbVie Inc. -- Forecasts and trends"' showing total 39 results
Start Over Descriptor "AbbVie Inc. -- Forecasts and trends" Publisher plus media solutions
39 results on '"AbbVie Inc. -- Forecasts and trends"'

1. Global Antibiotics Market- Featuring Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, and Bayer AG, Among Others | Technavio

Subjects
Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Antibiotics -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following press release: The antibiotics market is poised to grow by USD 4.44 billion during 2020-2024, progressing at a CAGR of over 3% during [...]

Published
2020

2. Global DNA Damage Response Drugs Market Analysis and Competitor Profiles 2020, Featuring AbbVie Inc., AstraZeneca plc, Bayer AG, Pfizer Inc. and More

Subjects
Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, DNA damage -- Forecasts and trends, Drugs -- Forecasts and trends, DNA -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, DNA repair -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global DNA Damage Response Drugs Market: Focus on Commercialized Drugs, Potential Pipeline Drugs, Application, Country Data (13 Countries), and [...]

Published
2020

3. Analysis on Impact of COVID-19- ENT Disorder Treatment Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and ALK-Abello AS | Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, COVID-19 -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following press release: The global ENT disorder treatment market is expected to grow by USD 1.32 billion as per Technavio. This marks a significant [...]

Published
2020

4. Global Monoclonal Antibodies Market 2020-2024: COVID-19 Business Continuity Plan | Evolving Opportunities with AbbVie Inc. and AstraZeneca Plc | Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Business planning -- Forecasts and trends -- Reports, Disaster recovery (Computers) -- Reports -- Forecasts and trends, Atezolizumab -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Emergency preparedness -- Forecasts and trends -- Reports, COVID-19 -- Reports -- Forecasts and trends, Adalimumab -- Forecasts and trends -- Reports, Disaster recovery, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following press release: The global monoclonal antibodies market size is expected to grow by USD 54.55 billion as per Technavio. This marks a significant [...]

Published
2020

5. Insights on the Global Medical Aesthetics Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio

Subjects
Hologic Inc. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Danaher Corp. -- Forecasts and trends, 3M Co. -- Forecasts and trends, Bausch Health Companies Inc. -- Forecasts and trends, Zimmer Biomet Holdings, Inc. -- Forecasts and trends, Paper products industry -- Forecasts and trends, Medical equipment industry -- Forecasts and trends, Motor vehicle drivers -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, COVID-19 -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the medical aesthetics market and it is poised to grow by USD 7.64 billion during 2020-2024, progressing [...]

Published
2020

6. Analysis on Impact of COVID-19- Global Hepatocellular Carcinoma Drugs Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio

Subjects
Amgen Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Durvalumab -- Forecasts and trends, Hepatocellular carcinoma -- Forecasts and trends, Chemotherapy -- Forecasts and trends, Biotechnology industries -- Forecasts and trends, Pembrolizumab -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Talimogene laherparepvec -- Forecasts and trends, COVID-19 -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: The global hepatocellular carcinoma drugs market size is expected to grow by USD 85.10 million as per Technavio. This marks a [...]

Published
2020

7. COVID-19 Impacts: Antiviral Drugs Market Will Accelerate at a CAGR of Over 9% Through 2020-2024 | Growing Cases of Viral Infections to Boost Growth | Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Health aspects, Pharmaceutical industry -- Forecasts and trends, Biological products industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the antiviral drugs market and it is poised to grow by USD 43.37 billion during 2020-2024, progressing [...]

Published
2020

8. Analysis on Impact of COVID-19- Global Cosmetic Surgery Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Alma Lasers GmbH | Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Bausch Health Companies Inc. -- Forecasts and trends, Plastic surgery -- Reports -- Forecasts and trends, Lasers -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Laser, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following press release: The global cosmetic surgery market size is expected to grow by USD 11.24 billion as per Technavio. This marks a significant [...]

Published
2020

9. Research Report with COVID-19 Forecasts- Gastrointestinal Diseases Therapeutics Market 2020-2024 | Increasing Incidence of Gastrointestinal Diseases to Boost Growth | Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Bausch Health Companies Inc. -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, UCB S.A. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Gastrointestinal diseases -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the gastrointestinal diseases therapeutics market and it is poised to grow by USD 22.82 billion during 2020-2024, [...]

Published
2020

10. Research Report with COVID-19 Forecasts- Pediatric Medicines Market 2020-2024 | Formulatory Advancement to Boost Growth | Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Drugs -- Reports -- Forecasts and trends, Pediatrics -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the pediatric medicines market and it is poised to grow by USD 27.71 billion during 2020-2024, progressing [...]

Published
2020

11. Analysis on Impact of COVID19-PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2020-2024 | Expanded Application of PARP Inhibitors to Boost Growth | Technavio

Subjects
Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Daiichi Sankyo Company Ltd. -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Monosaccharides -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the PARP (Poly ADP-ribose Polymerase) inhibitors market and it is poised to grow by USD 810.23 million [...]

Published
2020

12. Analysis on New Product Launches in Covid-19 Related Markets-Cancer Cachexia Therapeutics Market 2019-2023 | High Prevalence and Incidence Of Cancer Cachexia To Boost Growth | Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Mylan N.V. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, ANI Pharmaceuticals Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Cancer -- Forecasts and trends -- Reports, Medical equipment industry -- Forecasts and trends, Cachexia -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the cancer cachexia therapeutics market and it is poised to grow by USD 568.85 mn during 2019-2023, [...]

Published
2020

13. FORM 8-K: ALLERGAN PLC Files Current Report (Updated on March 18, 2020)

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends -- International economic relations, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends -- International economic relations, Jurisdiction, Public relations executives, Technology, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ALLERGAN PLC, has filed FORM 8K (Current Report) with Securities and Exchange Commission on March 18, 2020: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

Published
2020

14. FORM 8-K: ALLERGAN PLC Files Current Report (Updated on March 03, 2020)

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends -- International economic relations, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends -- International economic relations, Jurisdiction, Public relations executives, Technology, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ALLERGAN PLC, has filed FORM 8K (Current Report) with Securities and Exchange Commission on March 03, 2020: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

Published
2020

15. Global Ophthalmology Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Aerie Pharmaceuticals Inc. | Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Glaucoma, Retail trade, Eye diseases, Infection, Eye infections, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: The ophthalmology therapeutics market is poised to grow by USD 10.42 billion during 2020-2024, progressing at a CAGR of almost 6% [...]

Published
2020

16. AbbVie Inc. - 0QCV Disposal

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, London Stock Exchange PLC -- Forecasts and trends, Securities industry -- Forecasts and trends -- International economic relations, Ulcerative colitis, Vedolizumab, Stock exchanges, Pharmaceutical industry -- Forecasts and trends -- International economic relations, Adalimumab, Stock offerings, Colitis, Diseases, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Zenpep (Medication)
Abstract

London: London Stock Exchange plc has issued the following announcement: AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan (NYSE: AGN), a leading global pharmaceutical company, today announced that [...]

Published
2020

17. FORM 8-K: ALLERGAN PLC Files Current Report (Updated on January 27, 2020)

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends -- International economic relations, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends -- International economic relations, Jurisdiction, Public relations executives, Technology, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ALLERGAN PLC, has filed FORM 8K (Current Report) with Securities and Exchange Commission on January 27, 2020: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

Published
2020

18. Global ENT Disorder Treatment Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Bayer AG | Technavio

Subjects
Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Medical research, Pharmaceutical industry -- Forecasts and trends, Tonsillitis, Rhinitis, Otitis media, Otitis, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the global ENT disorder treatment market since 2017 and the market is poised to grow by USD [...]

Published
2020

19. Global Eczema Therapeutics Market 2020-2024| Evolving Opportunities with AbbVie Inc. and Bayer AG | Technavio

Subjects
Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Health care costs, Eczema, Atopic dermatitis, Pharmaceutical industry -- Forecasts and trends, Medical economics, Contact dermatitis, Dermatitis, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the global eczema therapeutics market and the market is poised to grow by USD 3.60 billion during [...]

Published
2019

20. Worldwide Markets for Breast Cancer Diagnostic & Drug Technologies, 2018-2019 & 2024 - Increased Demand for Technology Innovation Drives the Market

Subjects
AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Drugs -- Innovations -- Supply and demand, Epidemiology, Pharmaceutical industry -- Forecasts and trends, Breast cancer -- Drug therapy, Mortality, Technology, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

IRELAND: Research and Markets has issued the following press release: The 'Breast Cancer Diagnostic and Drug Technologies: Global Markets' report has been added to ResearchAndMarkets.com's offering. The objective of the [...]

Published
2019

21. AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes

Subjects
Allergan Inc. (Irvine, California) -- Forecasts and trends, Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Securities offerings, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NORTH CHICAGO: AbbVie has issued the following press release: AbbVie Inc. (NYSE:ABBV) ('AbbVie') announced today the extension of the expiration date of the offers to exchange (each, an 'Exchange Offer' [...]

Published
2019

22. Moody's assigns Baa2 to AbbVie's new sr. notes; stable outlook

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Moody's Investors Service Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') assigned a Baa2 rating to AbbVie Inc.'s ('AbbVie') new senior unsecured note offering. There [...]

Published
2019

23. FORM 8-K: ABBVIE INC. Files Current Report (Updated on November 07, 2019)

Subjects
United States. Securities and Exchange Commission, Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends, Jurisdiction, Public relations executives, Accounting departments, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ABBVIE INC., has filed FORM 8K (Current Report) with Securities and Exchange Commission on November 07, 2019: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT [...]

Published
2019

24. Moody's assigns Baa2 to AbbVie's exchange note offering

Subjects
Allergan Inc. (Irvine, California) -- Forecasts and trends, Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Moody's Investors Service Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') assigned a Baa2 rating to AbbVie Inc.'s ('AbbVie') proposed new senior unsecured exchange note [...]

Published
2019

25. World Endometriosis Drugs Market Report 2019-2023

Subjects
Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Drug delivery systems, Drugs, Patient compliance, Pharmaceutical industry -- Forecasts and trends, Endometriosis, Hormones, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Endometriosis Drugs Market by Product, RoA, and Geography - Global Forecast & Analysis 2019-2023' report has been added to [...]

Published
2019

26. Global Anesthesia Gases Market Report 2019 | Market Projected to Reach $1.97 Billion by 2024

Subjects
AbbVie Inc. -- Forecasts and trends, Chronic diseases, Gas industry -- Forecasts and trends -- Statistics, Natural gas -- Statistics, Pharmaceutical industry -- Forecasts and trends -- Statistics, Anesthesia, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Anesthesia Gases Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's offering. The [...]

Published
2019

27. FORM 8-K: ALLERGAN PLC Files Current Report (Updated on September 27, 2019)

Subjects
United States. Securities and Exchange Commission, Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends -- International economic relations, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends -- International economic relations, Jurisdiction, Public relations executives, Accounting departments, Technology, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ALLERGAN PLC, has filed FORM 8K (Current Report) with Securities and Exchange Commission on September 27, 2019: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

Published
2019

28. Moody's assigns Baa2 to AbbVie's euro notes; stable outlook

Subjects
Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Moody's Investors Service Inc. -- Forecasts and trends, Securities offerings, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') assigned a Baa2 rating to the new senior unsecured euro-denominated notes offering of AbbVie [...]

Published
2019

29. FORM 8-K: ABBVIE INC. Files Current Report (Updated on September 16, 2019)

Subjects
United States. Securities and Exchange Commission, Allergan PLC -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends, Stock exchanges, Securities law, Pharmaceutical industry -- Forecasts and trends, Jurisdiction, Public relations executives, Accounting departments, Employers, Securities industry, Market trend/market analysis, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ABBVIE INC., has filed FORM 8K (Current Report) with Securities and Exchange Commission on September 16, 2019: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT [...]

Published
2019

30. FORM 8-K: ALLERGAN PLC Files Current Report (Updated on September 16, 2019)

Subjects
United States. Securities and Exchange Commission, Allergan PLC -- Forecasts and trends, JPMorgan Chase & Co. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Financial statements, Securities industry -- Forecasts and trends, Stock exchanges, Banking industry -- Forecasts and trends, Securities law, Pharmaceutical industry -- Forecasts and trends, Jurisdiction, Public relations executives, Accounting departments, Technology, Employers, Securities industry, Market trend/market analysis, Banking industry, General interest, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: ALLERGAN PLC, has filed FORM 8K (Current Report) with Securities and Exchange Commission on September 16, 2019: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

Published
2019

31. Global Biopharmaceuticals Market Overview, 2018-2019 & Forecast to 2025

Subjects
Eli Lilly and Co. -- Forecasts and trends, Roche Holding AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Biogen Inc. -- Forecasts and trends, Chronic diseases, Biotechnology industries -- Forecasts and trends, Biopharmaceuticals, Pembrolizumab, Pharmaceutical industry -- Forecasts and trends, Pemetrexed, Biological products industry -- Forecasts and trends, Adalimumab, Dasatinib, Monoclonal antibodies, Antibodies, Biological products, Elderly, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Biopharmaceuticals - A Global Market Overview' report has been added to ResearchAndMarkets.com's offering. Global demand for Biopharmaceuticals by product [...]

Published
2019

32. The World Market for Endometriosis 2015-2019 & 2022 - Uptrend in Healthcare Expenditure Creates Substantial Opportunities

Subjects
United States. Food and Drug Administration, AbbVie Inc. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Bayer AG -- Forecasts and trends, Health care costs, Nafarelin, Pharmaceutical industry -- Forecasts and trends, Endometriosis, Medical economics, Market trend/market analysis, General interest, News, opinion and commentary, Endometriosis Research Center
Abstract

Dublin: Research and Markets has issued the following press release: The 'Endometriosis: Global Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. This report provides separate comprehensive [...]

Published
2019

33. Endometriosis: Global Market Analysis, Trends and Forecasts to 2022 - Steady Growth Expected Over the Next Few Years

Subjects
United States. Food and Drug Administration, AbbVie Inc. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Bayer AG -- Forecasts and trends, Nafarelin, Pharmaceutical industry -- Forecasts and trends, Endometriosis, Market trend/market analysis, General interest, News, opinion and commentary, Endometriosis Research Center
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Endometriosis: Global Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. This report provides separate comprehensive [...]

Published
2019

34. Global Immunotherapy Drugs Market to 2025: Market will Grow at a CAGR of 12.5% - Key Vendors are AbbVie, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Johnson & Johnson, & Merck & Co

Subjects
F. Hoffmann-La Roche Ltd. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Chronic diseases, Drugs, Biotechnology industries -- Forecasts and trends, Immunotherapy, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Vendor relations, Novels, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Immunotherapy Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025' report has been added to [...]

Published
2019

35. New Research: Key Drivers of Growth for AbbVie, TriNet Group, ACI Worldwide, and IMV INC -- Factors of Influence, Major Initiatives and Sustained Production

Subjects
AbbVie Inc. -- Forecasts and trends, TriNet Group Inc. -- Forecasts and trends, ACI Worldwide Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Software industry -- Forecasts and trends, Stockholders, Accounting departments, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Market Source Research has issued the following news release: In new independent research reports released early this morning, Market Source Research released its latest key findings for all [...]

Published
2019

36. Global Parkinson's Disease Drugs Market to 2024 - Key Players are Novartis, Roche, AbbVie, Teva Pharmaceutical, Pfizer, STADA Arzneimittel, GSK, Valeant, Merck & Co, and Amneal Pharma

Subjects
Novartis AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Valeant Pharmaceuticals International, Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Drugs, Antiparkinson agents, Industrialized countries, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

IRELAND: Research and Markets has issued the following press release: The 'Global Parkinson's Disease Drugs Market 2018-2024' report has been added to ResearchAndMarkets.com's offering. Global Parkinson's Disease Drugs Market is [...]

Published
2019

37. Global $5.6 Bn Parkinson's Disease Drugs Markets, 2018-2019 & 2024 - Supportive initiatives from Government and Other Organizations & Exhaustive Pipeline and Increasing Clinical Trials

Subjects
AbbVie Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Drugs, Antiparkinson agents, Industrialized countries, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: - The 'Global Parkinson's Disease Drugs Market 2018-2024' report has been added to ResearchAndMarkets.com's offering. Global Parkinson's Disease Drugs Market [...]

Published
2019

38. Global Parkinson's Disease Drugs Market is Expected to Witness a CAGR of 7.2% to Reach Revenue of $5,614.6 Million by 2024

Subjects
AbbVie Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Drugs, Antiparkinson agents, Industrialized countries, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Parkinson's Disease Drugs Market 2018-2024' report has been added to ResearchAndMarkets.com's offering. Global Parkinson's Disease Drugs Market is [...]

Published
2019

39. The Global Market for Cell Separation & Characterization in Solid Tumors (2018-2023): Abbvie, AstraZeneca, Beckman Coulter, Daiichi Sankyo and Pfizer are Dominating

Subjects
AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release:The 'Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023' report has been added to ResearchAndMarkets.com's offering.This report consists [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results